WASHINGTON, D.C. 20549
                                    FORM 8-K
                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of

                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                February 7, 2006

                           USANA HEALTH SCIENCES, INC.
             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

             Utah                                       87-0500306
-------------------------------                 ------------------------------
(State or other jurisdiction of                (IRS Employer Identification
        incorporation)                                    Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))

Item 2.02         Results of Operations and Financial Condition.

On February 7, 2006, USANA Health Sciences, Inc. issued a press release
announcing its financial results for the fourth quarter and fiscal year ended
December 31, 2005. The release also announced that executives of the company
would discuss these results with investors on a conference call broadcast over
the World Wide Web and by telephone and provided access information, date, and
time for the conference call. A copy of the press release is furnished herewith
as Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by
reference. The company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.

The information in this Current Report is being furnished and shall not be
deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that Section. The
information in this Current Report shall not be incorporated by reference into
any registration statement or other document pursuant to the Securities Act of
1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly

Item 9.01         Financial Statements and Exhibits.

                  (d)  Exhibits

Exhibit 99        Press release issued by USANA Health Sciences, Inc.
                  dated February 7, 2006 (furnished herewith).


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                 USANA HEALTH SCIENCES, INC.

                                 By: /s/ Gilbert A. Fuller
                                 Gilbert A. Fuller, Chief Financial Officer

Date: February 7, 2006